Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zuckerman

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 29, 2025
Early detection of a circulating pre-vaccine-derived poliovirus type 1 (pre-VDPV1) variant linked to an acute flaccid polio case prior to VDPV1 emergence, Israel, 2024 to 2025Neta S Zuckerman, Yaniv Lustig, Danit Sofer, et al.
Vaccines|July 2, 2021
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in IsraelNeta S Zuckerman, Shay Fleishon, Efrat Bucris, et al.
The Science of the Total Environment|February 4, 2023
Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis caseMerav Weil, Danit Sofer, Lester M Shulman, et al.
Breast Cancer Research and Treatment|March 12, 2022
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian JewsS Lieberman, R Chen-Shtoyerman, Z Levi, et al.
Viruses|December 23, 2023
Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Daniel Elbirt, et al.
Viruses|January 22, 2022
Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018Tali Wagner, Neta S Zuckerman, Tami Halperin, et al.
Eclinicalmedicine|December 6, 2021
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort studyShepherd R Singer, Frederick J Angulo, David L Swerdlow, et al.
The Lancet. Microbe|September 16, 2024
Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology studyNeta S Zuckerman, Efrat Bucris, Hagar Morad-Eliyahu, et al.
The Journal of Infectious Diseases|July 27, 2025
Clinical and environmental surveillance of poliovirus type 2 outbreak using a novel specific real-time quantitative PCR assay, Israel, 2022-2023Itay Bar-Or, Merav Weil, Hadar Assraf, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 16, 2022
Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022Neta S Zuckerman, Itay Bar-Or, Danit Sofer, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 29, 2025
Early detection of a circulating pre-vaccine-derived poliovirus type 1 (pre-VDPV1) variant linked to an acute flaccid polio case prior to VDPV1 emergence, Israel, 2024 to 2025Neta S Zuckerman, Yaniv Lustig, Danit Sofer, et al.
Vaccines|July 2, 2021
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in IsraelNeta S Zuckerman, Shay Fleishon, Efrat Bucris, et al.
The Science of the Total Environment|February 4, 2023
Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis caseMerav Weil, Danit Sofer, Lester M Shulman, et al.
Breast Cancer Research and Treatment|March 12, 2022
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian JewsS Lieberman, R Chen-Shtoyerman, Z Levi, et al.
Viruses|December 23, 2023
Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in IsraelTali Wagner, Itzchak Levy, Daniel Elbirt, et al.
Viruses|January 22, 2022
Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018Tali Wagner, Neta S Zuckerman, Tami Halperin, et al.
Eclinicalmedicine|December 6, 2021
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort studyShepherd R Singer, Frederick J Angulo, David L Swerdlow, et al.
The Lancet. Microbe|September 16, 2024
Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology studyNeta S Zuckerman, Efrat Bucris, Hagar Morad-Eliyahu, et al.
The Journal of Infectious Diseases|July 27, 2025
Clinical and environmental surveillance of poliovirus type 2 outbreak using a novel specific real-time quantitative PCR assay, Israel, 2022-2023Itay Bar-Or, Merav Weil, Hadar Assraf, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 16, 2022
Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022Neta S Zuckerman, Itay Bar-Or, Danit Sofer, et al.
Pageof 33